Related Experiment Video

Updated: Aug 8, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

Penicillin prophylaxis and neonatal streptococcal disease

H L Hodes

    Hospital Practice
    |March 1, 1980
    PubMed

    Insights

    Preventing neonatal Group B Streptococcus (GBS) infection remains challenging. However, penicillin prophylaxis for infant eye infections shows promise in protecting against GBS, with large studies ongoing.

    Area of Science:

    • Neonatal infectious diseases
    • Microbiology
    • Pharmacology

    Background:

    • Neonatal Group B beta-hemolytic Streptococcus (GBS) infections pose a significant health risk.
    • Current methods for preventing GBS, including maternal treatment and immunization, have proven ineffective.
    • There is a critical need for novel strategies to prevent neonatal GBS.

    Purpose of the Study:

    • To investigate the potential of routine penicillin prophylaxis in preventing neonatal GBS infections.
    • To evaluate the serendipitous observation of GBS protection associated with penicillin prophylaxis for gonococcal ophthalmia.

    Main Methods:

    • Observational data analysis of infants receiving routine penicillin prophylaxis for gonococcal ophthalmia.
    • Initiation of large-scale controlled studies to confirm findings.

    Main Results:

    • Routine penicillin prophylaxis for gonococcal ophthalmia demonstrated a protective effect against neonatal GBS.
    • This finding provides a new potential avenue for GBS prevention.

    Conclusions:

    • Penicillin prophylaxis for gonococcal ophthalmia may serve as an indirect method for preventing neonatal GBS infections.
    • Further large-scale controlled studies are warranted to validate this protective effect and establish its efficacy.

    More Related Videos

    Probiotic Studies in Neonatal Mice Using Gavage10:36

    Probiotic Studies in Neonatal Mice Using Gavage

    Published on: January 27, 2019

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

    Published on: August 12, 2020

    Related Concept Videos

    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    Production of Antibiotics01:27

    Production of Antibiotics

    Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Streptococcal Pharyngitis01:27

    Streptococcal Pharyngitis

    Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
    Diphtheria01:28

    Diphtheria

    Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...